Wataya-Kaneda, Mari <br/><br/>
A novel application of topical rapamycin formulation, an inhibitor of mTOR, for patients with hypomelanotic macules in tuberous sclerosis complex.  [electronic resource] 

 -  Archives of dermatology  Jan 2012 
 - 138-9 p.  digital 
<br/><br/> Publication Type: Case Reports; Letter; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1538-3652 
<br/><br/><label>Standard No.: </label>10.1001/archderm.148.1.138  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Topical<br/>Child<br/>Child, Preschool<br/>Humans<br/>Hypopigmentation--drug therapy<br/>Male<br/>Sirolimus--administration & dosage<br/>TOR Serine-Threonine Kinases--antagonists & inhibitors<br/>Tuberous Sclerosis--complications